Features of Orthopedic Rehabilitation of Patients with Maxillofacial Defects and Post-Covid Complications of the Upper Jaw
Keywords:
COVID-19, SARS-CoV-2, oral cavity, dental statusAbstract
One of the current tasks in dentistry is to improve the principles of providing orthopedic care to patients with the consequences of various injuries and surgical interventions on the tissues of the maxillofacial region. The importance of this issue is justified by the annual increase in the number of patients who have suffered from road traffic accidents, industrial accidents and catastrophes, as well as those who have undergone surgical interventions for neoplasms, deformities, and defects of the maxillofacial region caused by acute purulent and inflammatory diseases due to COVID-19.
References
[1] S. Adhikari, S. Meng, Y. Wu, Y. Mao, R. Ye, Q. Wang, C. Sun, S. Sylvia, S. Rozelle, H. Raat, et al., “Epidemiology, causes, clinical manifestations and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review,” Infectious Diseases of Poverty, vol. 9, pp. 1–12, 2020.
[2] J. Amorim dos Santos et al., “Oral manifestations in patients with COVID-19: A living systematic review,” Journal of Dental Research, vol. 99, pp. 141–154, 2020.
[3] K. Ayub and A. Alani, “Acute endodontic and dental trauma provision during the COVID-19 crisis,” British Dental Journal, vol. 229, pp. 169–175, 2020.
[4] D. A. Brandini, A. S. Takamiya, P. Thakkar, S. Schaller, R. Rahat, and A. R. Naqvi, “COVID-19 and oral diseases: Crosstalk, synergy or association?” Reviews in Medical Virology, 2021.
[5] M. Cascella, M. Rajnik, A. Cuomo, S. C. Dulebohn, and R. Di Napoli, “Features, evaluation and treatment of coronavirus (COVID-19),” in StatPearls, Treasure Island, FL, USA: StatPearls Publishing, 2020.
[6] Centers for Disease Control and Prevention, “CDC updates, expands list of people at risk of severe COVID-19 illness,” 2020. [Online]. Available: https://www.cdc.gov
[7] W. J. Guan, Z. Y. Ni, Y. Hu, W. H. Liang, C. Q. Ou, J. X. He, L. Liu, H. Shan, C. L. Lei, and D. S. Hui, et al., “Clinical characteristics of coronavirus disease 2019 in China,” New England Journal of Medicine, vol. 382, pp. 1708–1720, 2020.
[8] Y. R. Guo, Q. D. Cao, Z. S. Hong, S. D. Chen, H. G. Jin, K. S. Tan, D. Y. Wang, and Y. Yan, “The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – An updated status,” Military Medical Research, vol. 7, pp. 1–10, 2020.
[9] J. M. Jin et al., “Gender differences in patients with COVID-19: Focus on severity and mortality,” Frontiers in Public Health, vol. 8, p. 152, 2020.
[10] X. Peng, X. Xu, Y. Li, L. Cheng, X. Zhou, and B. Ren, “Transmission routes of 2019-nCoV and controls in dental practice,” International Journal of Oral Science, vol. 12, pp. 1–6, 2020.
[11] S. Sharipov and N. L. Xabilov, “Methods of safety of dental prosthetic practice during the COVID-19 pandemic,” Eurasian Journal of Academic Research, pp. 845–854, May 2021.
[12] M. Tay, C. Poh, L. Rénia, P. MacAry, and L. Ng, “The trinity of COVID-19: Immunity, inflammation and intervention,” Nature Reviews Immunology, vol. 20, pp. 363–374, 2020.
[13] N. van Doremalen, T. Bushmaker, D. H. Morris, et al., “Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1,” New England Journal of Medicine, vol. 382, pp. 1564–1567, 2020.
[14] M. Villa, “La Letalità in Italia: Tra Apparenza e Realtà,” 2020. [Online]. Available: https://www.ispionline.it
[15] N. L. Xabilov and S. S. Sharipov, “Interdisciplinary research: Scientific horizons and perspectives,” in Proc. Int. Scientific and Theoretical Conference, vol. 3, Vilnius, 2021.
[16] P. Zhou, X. L. Yang, X. G. Wang, B. Hu, L. Zhang, W. Zhang, H. R. Si, Y. Zhu, B. Li, and C. L. Huang, et al., “A pneumonia outbreak associated with a new coronavirus of probable bat origin,” Nature, vol. 579, pp. 270–273, 2020.
[17] N. Zhu, D. Zhang, W. Wang, et al., “A novel coronavirus from patients with pneumonia in China, 2019,” New England Journal of Medicine, vol. 382, pp. 727–733, 2020.
[18] X. Zou et al., “Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals potential risk of different human organs vulnerable to 2019-nCoV infection,” Frontiers in Medicine, 2020.
[19] D. Wang, B. Hu, C. Hu, et al., “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China,” JAMA, vol. 323, pp. 1061–1069, 2020.
[20] World Health Organization, “Novel coronavirus (2019-nCoV) situation report,” 2021. [Online]. Available: https://www.who.int
[21] A. Kamel, A. Basuoni, Z. Salem, et al., “The impact of oral health status on COVID-19 severity, recovery period and C-reactive protein values,” British Dental Journal, 2021.
[22] R. Lu, X. Zhao, J. Li, et al., “Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding,” The Lancet, vol. 395, pp. 565–574, 2020.
[23] N. S. Madaminova, A. N. Akbarov, and N. S. Ziyadullaeva, “The oral cavity as an entry gate in COVID-19 infection,” Journal of Medicine Innovations, vol. 1, pp. 22–25, 2021.
[24] S. Martín-Carreras-Presas, J. Amaro-Sánchez, A. F. López-Sánchez, E. Jané-Salas, and M. L. Somacarrera Pérez, “Oral vesiculobullous lesions associated with SARS-CoV-2 infection,” Oral Diseases, 2020.
[25] A. Sophie-Mahmudi, “Patients with COVID-19 may have some oral manifestations,” Evidence-Based Dentistry, vol. 22, pp. 80–81, 2021.
[26] K. Tran, K. Cimon, M. Severn, C. Pessoa-Silva, and J. Conly, “Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: A systematic review,” PLoS ONE, 2012, doi:10.1371/journal.pone.0035797.
[27] A. Estébanez, L. Pérez-Santiago, E. Silva, S. Guillén-Climent, A. García-Vázquez, and M. D. Ramón, “Cutaneous manifestations in COVID-19: A new contribution,” Journal of the European Academy of Dermatology and Venereology, 2020, doi:10.1111/jdv.16474.
